Dermata Therapeutics, Inc.
DRMA
$0.8104
$0.00040.05%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -57.64% | -53.75% | -22.16% | 4.15% | 18.90% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 25.93% | 23.06% | 20.62% | 15.23% | -43.87% |
| Change in Net Operating Assets | -45.95% | 400.89% | 314.60% | -27.40% | 662.24% |
| Cash from Operations | -74.18% | -32.59% | 1.62% | 5.23% | 27.45% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -8.97% | 56.66% | -23.27% | -58.99% | 78.67% |
| Repurchase of Common Stock | -96.05% | 97.74% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -9.46% | 57.63% | -25.13% | -59.41% | 77.84% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -457.28% | 66.02% | -59.48% | -800.42% | 126.26% |